AFib Anticoagulation: Stroke vs Bleed Risk
CHADS2 stroke risk and HAS-BLED bleed risk side by side — the actual tradeoff clinicians weigh, not two separate scores in isolation. Not a substitute for a clinician’s judgment.
Not medical advice. CHADS2 and HAS-BLED are decision-support tools, not a treatment recommendation. The anticoagulation decision weighs these scores alongside a patient's full history — discuss your results with a clinician before acting on them.